BCG vaccination induces HIV target cell activation in HIV-exposed infants in a randomized trial

BACKGROUND. Bacillus Calmette-Guérin (BCG) vaccine is administered at birth to protect infants against tuberculosis throughout Africa, where most perinatal HIV-1 transmission occurs. We examined whether BCG vaccination alters the levels of activated HIV target T cells in HIV-exposed South African in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JCI Insight
Autors principals: Gasper, Melanie A., Hesseling, Anneke C., Mohar, Isaac, Myer, Landon, Azenkot, Tali, Passmore, Jo-Ann S., Hanekom, Willem, Cotton, Mark F., Crispe, I. Nicholas, Sodora, Donald L., Jaspan, Heather B.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Clinical Investigation 2017
Matèries:
Clinical Medicine
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5374072/
https://ncbi.nlm.nih.gov/pubmed/28405623
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.91963
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars